ID | 542 |
No | 542 |
Brand Name | LOPID |
Ingredients | GEMFIBROZIL 600 MG |
Dosage Form | TABLET |
Primary Packaging | PVC-ALU BLISTER |
Storage | STORE BELOW 30'C |
Shelf Life | 60 MONTHS |
Pack Size | BOX OF 6 X 10'S |
Dispensing Category | Prescription only |
ATC Classification | B04AC04 |
Pharmaceutical Class | LIPID MODIFYING |
Indications | GEMFIBROZIL IS A LIPID REGULATIONG AGENT THAT IS INDICATED FOR THE FOLLOWING :
PRIMARY PREVENTION OF CORONARY HEART DISEASE (CHD) AND MYOCARDIAL INFARCTION (MI) IN PATIENTS WITH HYPERCHOLESTEROLEMIA, MIXED DYSLIPIDEMIA AND HYPERTRIGLYCERIDEMIA, FREDRICKSON'S CLASSIFICATION TYPES IIA, IIB AND IV. |
Contraindications | GEMFIBROZIL IS CONTRAINDICATED IN PATIENTS WITH HEPATIC OR SEVERS RENAL DYSFUNCTION, PRE EXISTING GALLBLADDER DISEASE, AND PATIENTS WHO ARE HYPERSENSITIVE TO GEMFIBROZIL OR ANY OF THE INERT INGREDIENTS |
Side Effects | HEPATOBILIARY DISORDERS : CHOLESTATIC JAUNDICE. |
Unit Price | USD 4.41/B |
EDL |
Yes |
Description | A WHITE -COATED, ELLIPTICAL, BICONVEX TABLETS WITH MONOGRAM '' LOPID'' ON ONE SIDE AND PLAIN ON THE OTHER SIDE. |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | OLIC (THAILAND) LIMITED |
Country | THAILAND |
Import Registration No | 1A 421/40 |
Import Registration Date | 1997-05-29 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-03-06 |
FDD Registration No | 11 I 3994/13 |
FDD Registration Date | 2024-06-22 |
Expiry Date | 2027-06-21 |